EMBECTA CORP

EMBC · NASDAQ

更新于 2026-10-15 10:31:47

$6.18-0.32%
今日最高
$6.25
今日最低
$6.11
EMBECTA CORP(EMBC)股价与市场数据
搜索空状态插图
...

K线图趋势,实际资料以交易页为准

关键数据

昨日开盘价
$6.19
昨日收盘价
$6.18
成交量
65.14万
市值
$3.5亿
本益比(P/E)
4.00X
每股收益(EPS)
$1.47

昨日价格区间

$6.11$6.25

52周价格区间

$2.77$14.91

公司概况

板块
HEALTHCARE
行业
Health Care
子行业
MEDICAL INSTRUMENTS & SUPPLIES
总部
300 KIMBALL DRIVE, PARSIPPANY, NJ, UNITED STATES, 07054
国家
US
上市日期
2022-03-21
财年截止
September
流通股数
5933万
CIK
0001872789
官方网址
www.embecta.com

Embecta Corp (EMBC) is a leading medical technology company specializing in innovative insulin delivery systems aimed at enhancing diabetes management. Born from a spin-off of Becton, Dickinson and Company, Embecta provides a comprehensive portfolio of advanced products, including cutting-edge insulin pens and syringes tailored to improve patient outcomes. With a robust focus on operational excellence and customer satisfaction, Embecta is well-positioned to capitalize on growth opportunities in the rapidly expanding diabetes care market, strengthening its leadership in this vital sector.

财务指标

营业收入

2026-06-30

$2.71亿

2026-03-31

$2.21亿

2025-12-31

$2.61亿

2025-09-30

$2.64亿

营业支出

2026-06-30

$1.04亿

2026-03-31

$8230万

2025-12-31

$7850万

2025-09-30

$9160万

净利润

2026-06-30

$2110万

2026-03-31

-$410万

2025-12-31

$4410万

2025-09-30

$2640万

净利润率

2026-06-30

7.76%

2026-03-31

-1.84%

2025-12-31

16.88%

2025-09-30

10%

每股收益

2026-06-30

$0.56

2026-03-31

$0.27

2025-12-31

$0.71

2025-09-30

$0.50

息税折旧摊销前利润

2026-06-30

$6470万

2026-03-31

$4490万

2025-12-31

$9590万

2025-09-30

$6040万

有效税率

2026-06-30

23.55%

2026-03-31

143.15%

2025-12-31

25.12%

2025-09-30

8.96%

常见问题

风险提示

股价可能大幅波动,短时间内可能出现显著涨跌。 数字资产与衍生品交易可能涉及杠杆、流动性等额外风险。 本页内容仅供参考,不构成任何投资建议。 产品可用性与访问可能因地区及适用法规而异。